Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 6, 2003, Pages 1777-1783

  Farrell, D J ^a   Douthwaite, S ^b   Morrissey, I ^a   Bakker, S ^a   Poehlsgaard, J ^b   Jakobsen, L ^b   Felmingham, D ^a  

^a GR Micro   (United Kingdom)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; KETOLIDE; LEVOFLOXACIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; MIKAMYCIN B; PENICILLIN G; PRIMER RNA; QUINUPRISTIN; RIBOSOME RNA; RNA 23S; ROKITAMYCIN; ROXITHROMYCIN; TELITHROMYCIN; TETRACYCLINE;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANADA; CLONE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GERMANY; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIBOSOME; RNA METHYLATION; RNA TRANSPORT; STREPTOCOCCUS PNEUMONIAE; TURKEY (REPUBLIC); UNITED STATES;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; MACROLIDES; PNEUMOCOCCAL INFECTIONS; POINT MUTATION; POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS PNEUMONIAE;

EID: 0012633768     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.6.1777-1783.2003     Document Type: Article

References (30)

1. Ban, N., P. Nissen, J. Hansen, P. B. Moore, and T. A. Steitz. 2000. The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution. Science 289:905-920.
2. Canu, A., B. Malbruny, M. Coquemont, T. Davies, P. C. Appelbaum, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:125-131.
3. Depardieu, F., and P. Courvalin. 2001. Mutations in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:319-323.
4. Descheemaeker, P., S. Chapelle, C. Lammens, M. Hauchecorne, M. Wijdooghe, P. Vandamme, et al. 2000. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J. Antimicrob. Chemother. 45:167-173.
5. Enright, M. C., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
6. Farrell, D. J., I. Morrissey, S. Bakker, and D. Felmingham. 2001. Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J. Antimicrob. Chemother. 48:541-544.
7. Farrell, D. J., I. Morrissey, S. Bakker, and D. Felmingham. 2002. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J. Antimicrob. Chemother. 50(Suppl. S1):39-47.
8. Hansen, J. L., J. A. Ippolito, N. Ban, P. Nissen, P. B. Moore, and T. A. Steitz. 2002. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell 10:117-128.
9. Hansen, L. H., P. Mauvais, and S. Douthwaite. 1999. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. Mol. Microbiol. 31:623-631.
10. Malbruny, B., A. Canu, B. Bozdogan, B. Fantin, V. Zarrouk, S. Dutka-Malen, C. Feger, and R. Leclercq. 2002. Resistance to quinupristin-dalfopristin due to mutation in L22 ribosomal protein in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2200-2207.
11. Nakatogawa, H., and K. Ito. 2002. The ribosomal exit tunnel functions as a discriminating gate. Cell 108:629-636.
12. National Committee for Clinical and Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. NCCLS document M7-A5. National Committee for Clinical and Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical and Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. NCCLS document M100-12. National Committee for Clinical and Laboratory Standards, Wayne, Pa.
14. Pihlajamäki, M., J. Kataja, H. Seppälä, J. Elliot, M. Leinonen, P. Huovinen, and J. Javala. 2002. Ribosomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob. Agents Chemother. 46:654-658.
15. Poehlsgaard, J., and S. Douthwaite. 2002. The macrolide binding site on the bacterial ribosome. Curr. Drug Targets Infect. Disorders 2:67-78.
16. Roberts, M. C., J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43:2823-2830.
17. Schlünzen, F., R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albrecht, A. Yonath, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821.
18. Schmitz, F. J., M. Perdikouli, A. Beeck, J. Verhoef, and A. C. Fluit. 2001. Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1911 clinical European Streptococcus pneumoniae isolates. Int. J. Antimicrob. Agents 18:433-436.
19. Sigmund, C. D., M. Ettayebi, A. Borden, and E. A. Morgen. 1988. Antibiotic resistance mutations in ribosomal RNA genes of Escherichia coli. Methods Enzymol. 164:673-690.
20. Skinner, R., E. Cundliffe, and F. J. Schmidt. 1983. Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. J. Biol. Chem. 258:12702-12706.
21. Stern, S., D. Moazed, and H. F. Noller. 1988. Structural analysis of RNA using chemical and enzymatic probing monitored by primer extension. Methods Enzymol. 164:481-489.
22. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
23. Syrogiannopoulos, G. A., I. N. Grivea, A. Tait-Kamradt, G. D. Katopodis, N. G. Beratis, J. Sutcliffe, P. C. Appelbaum, and T. A. Davies. 2001. Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrob. Agents Chemother. 45:342-344.
24. Tait-Kamradt, A., T. Davies, M. Cronan, M. R. Jacobs, P. C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.
25. Tait-Kamradt, A., T. Davies, P. C. Appelbaum, F. Depardieu, P. Courvalin, J. Petipas, L. Wondrack, A. Walker, M. R. Jacobs, and J. Sutcliffe. 2000. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44:3395-3401.
26. Tenson, T., and M. Ehrenberg. 2002. Regulatory nascent peptides in the ribosomal tunnel. Cell 108:591-594.
27. Usary, J., and W. S. Champney. 2001. Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells. Mol. Microbiol. 40:951-962.
28. Vester, B., and S. Douthwaite. 1994. Domain V of 23S rRNA contains all the structural elements necessary for recognition by the ErmE methyltransferase. J. Bacteriol. 176:6999-7004.
29. Vester, B., and S. Douthwaite. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45:1-12.
30. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585.